Abstract Twenty-nine of 172 patients (17%) who received an allogeneic bone marrow
transplant (BMT) from histocompatible sibling donors for hematologic malignancies were …

Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …

Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …

MATERIALS AND METHODS Patients. Twenty patients were transplanted with allogeneic
BM for the treatment of hematologic malignancies. Diagnosis, conditioning regimens …

Hematopoietic chimerism is a measure of the number of donor and recipient cells in the host
following stem cell transplantation (SCT). The type of conditioning therapy prior to SCT has a …

Recently, we have shown that patients with acute leukaemias and myelodysplastic
syndromes (MDS), who showed increasing mixed chimaerism (MC) upon serial PCR …

Since graft-versus-leukemia (GVL) is the main weapon for disease eradication after reduced
intensity conditioning (RIC) allogeneic SCT, the availability of sensitive and specific …

Aim: Mixed chimerism (MC) is a state in which there is a presence of both recipient and
donor haematopoietic cells and is frequently observed after bone marrow transplantation …

We analyzed donor-type chimerism in CD3+, CD14. 15+ and CD56+ cells from 36 patients
who had undergone conventional-intensity allogeneic stem cell transplantation (CST) and …

Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …